Disclosure Statement Pursuant to the Pink Basic Disclosure Guidelines
Springs Rejuvenation, Inc.
A Nevada Corporation
One Glenlake Parkway, Suite 650
Atlanta GA, 30328
SIC:3651
678-387-3515
Quarterly Report
For the Period Ending: 04/30/22
(the "Reporting Period")
As of 04/30/22, the number of shares outstanding of our Common Stock was: 217,682,208
As of 01/31/22, the number of shares outstanding of our Common Stock was: 205,182,208.
As of 01/31/2022, our last completed year end, the number of shares outstanding of our Common Stock was: 205,182,208.
Indicate by check mark whether the company is a shell company (as defined in Rule 405 of the Securities Act of 1933 and Rule 12b-2 of the Exchange Act of 1934):
Yes: ☐ | No: ☒ |
Indicate by check mark whether the company's shell status has changed since the previous reporting period:
Yes: ☐ | No: ☒ |
Indicate by check mark whether a Change in Control1 of the company has occurred over this reporting period:
Yes: ☐ | No: ☒ |
- "Change in Control" shall mean any events resulting in:
- Any "person" (as such term is used in Sections 13(d) and 14(d) of the Exchange Act) becoming the "beneficial owner" (as defined in Rule 13d-3 of the Exchange Act), directly or indirectly, of securities of the Company representing fifty percent (50%) or more of the total voting power represented by the Company's then outstanding voting securities;
- The consummation of the sale or disposition by the Company of all or substantially all of the Company's assets;
- A change in the composition of the Board occurring within a two (2)-year period, as a result of which fewer than a majority of the directors are directors immediately prior to such change; or
- The consummation of a merger or consolidation of the Company with any other corporation, other than a merger or consolidation which would result in the voting securities of the Company outstanding immediately prior thereto continuing to represent (either by remaining outstanding or by being converted into voting securities of the surviving entity or its parent) at least fifty percent (50%) of the total voting power represented by the voting securities of the Company or such surviving entity or its parent outstanding immediately after such merger or consolidation.
OTC Markets Group Inc. | |
OTC Pink Basic Disclosure Guidelines (v3.1 June 24, 2021) | Page 1 of 22 |
- Name and address(es) of the issuer and its predecessors (if any)
In answering this item, provide the current name of the issuer any names used by predecessor entities, along with the dates of the name changes.
The Issuer was originally incorporated on December 1, 2010, in the State of Nevada as Avra, Inc.
On March 9, 2022 the Company changed its name to Springs Rejuvenation, Inc. and changed it's trading symbol from AVRN to SPRJ.
The state of incorporation or registration of the issuer and of each of its predecessors (if any) during the past five years; Please also include the issuer's current standing in its state of incorporation (e.g. active, default, inactive):
The Issuer was originally incorporated on December 1, 2010, in the State of Nevada.
The Issuer's Corporate status is Activewith the State of Nevada.
Describe any trading suspension orders issued by the SEC concerning the issuer or its predecessors since inception:
None
List any stock split, stock dividend, recapitalization, merger, acquisition, spin-off, or reorganization either currently anticipated or that occurred within the past 12 months:
On October 30, 2021, Avra, Inc. entered into a definitive agreement to merge with Springs Rejuvenation LLC. Additionally, Dr. Robert Pereya was appointed to the Board of Directors and appointed Chief Operating Officer. The result of this transaction constituted a change of control of the Issuer.
The address(es) of the issuer's principal executive office:
One Glenlake Parkway, Suite 650, Atlanta GA, 30328
The address(es) of the issuer's principal place of business:
Check box if principal executive office and principal place of business are the same address: ☒
Has the issuer or any of its predecessors been in bankruptcy, receivership, or any similar proceeding in the past five years?
Yes: ☐ | No: ☒ |
If this issuer or any of its predecessors have been the subject of such proceedings, please provide additional details in the space below:
NA
OTC Markets Group Inc. | |
OTC Pink Basic Disclosure Guidelines (v3.1 June 24, 2021) | Page 2 of 22 |
2) | Security Information | ||
Trading symbol: | SPRJ | ||
Exact title and class of securities outstanding: | Common | ||
CUSIP: | 05453B304 | ||
Par or stated value: | 0.00001 | ||
Total shares authorized: | 750,000,000 | as of date: 04/30/22 | |
Total shares outstanding: | 217,682,208 as of date: 04/30/22 | ||
Number of shares in the Public Float2: | 56,860,458 | as of date: 04/30/22 | |
Total number of shareholders of record: | 30 | as of date: 04/30/22 |
All additional class(es) of publicly traded securities (if any):
Trading symbol: | NA | |
Exact title and class of securities outstanding: | Class A Preferred | |
CUSIP: | NA | |
Par or stated value: | 0.00001 | |
Total shares authorized: | 75,000,000 | as of date: 04/30/22 |
Total shares outstanding: | 10,000,000 | as of date: 04/30/22 |
Trading symbol: | NA |
Transfer Agent
Name: Pacific Stock Transfer
Phone: 1-800-785-7782
Email: info@pacificstocktransfer.com
Address: 6725 Via Austi Parkway #300
Las Vegas NV, 89119
Is the Transfer Agent registered under the Exchange Act?3 Yes: ☒ | No: ☐ |
- Issuance History
- "Public Float" shall mean the total number of unrestricted shares not held directly or indirectly by an officer, director, any person who is the beneficial owner of more than 10 percent of the total shares outstanding (a "control person"), or any affiliates thereof, or any immediate family members of officers, directors and control persons.
- To be included in the Pink Current Information tier, the transfer agent must be registered under the Exchange Act.
OTC Markets Group Inc. | |
OTC Pink Basic Disclosure Guidelines (v3.1 June 24, 2021) | Page 3 of 22 |
The goal of this section is to provide disclosure with respect to each event that resulted in any direct changes to the total shares outstanding of any class of the issuer's securities in the past two completed fiscal years and any subsequent interim period.
Disclosure under this item shall include, in chronological order, all offerings and issuances of securities, including debt convertible into equity securities, whether private or public, and all shares, or any other securities or options to acquire such securities, issued for services. Using the tabular format below, please describe these events.
A. Changes to the Number of Outstanding Shares
Check this box to indicate there were no changes to the number of outstanding shares within the past two completed fiscal years and any subsequent periods: ☐
Example: A company with a fiscal year end of December 31st, in addressing this item for its quarter ended June 30, 2021, would include any events that resulted in changes to any class of its outstanding shares from the period beginning on January 1, 2019 through June 30, 2021 pursuant to the tabular format above.
Shares Outstanding as of Second Most Recent | |||||||||
Fiscal Year End: | *Right-click the rows below and select "Insert" to add rows as needed. | ||||||||
Opening Balance | |||||||||
Date 01/31/17 | Common: 63,397,094 | ||||||||
Preferred: 0 | |||||||||
Date of | Transaction | Number of | Class of | Value of | Were the | Individual/ Entity | Reason for share | Restricted or | Exemption |
Transaction | type (e.g. new | Shares | Securities | shares | shares | Shares were | issuance (e.g. for | Unrestricted | or |
issuance, | Issued (or | issued | issued at | issued to | cash or debt | as of this | Registration | ||
cancellation, | cancelled) | ($/per | a discount | (entities must | conversion) | filing. | Type. | ||
shares | share) at | to market | have individual | -OR- | |||||
returned to | Issuance | price at | with voting / | Nature of | |||||
treasury) | the time | investment | Services | ||||||
of | control | Provided | |||||||
issuance? | disclosed). | ||||||||
(Yes/No) | |||||||||
01/21/21 | New | 90,000,000 | Common | $0.0001 | Yes | Everett | Compensation | Restricted | 4(a)2 |
Issuance | Dickson | ||||||||
02/04/21 | New | 14,685, 114 | Common | $0.0007 | Yes | Device Corp. | Debt | Free | 4(a)1 |
issuance | E L Harris | conversion | trading | ||||||
Principal | |||||||||
03/31/21 | New | 14,800,000 | Common | $0.0007 | Yes | Anything | Debt | Free | 4(a)1 |
issuance | Media Corp | Conversion | trading | ||||||
Chris Jensen | |||||||||
06/23/21 | New | 14,800,000 | Common | $0.0001 | Yes | Device Corp. | Debt | Free | 4(a)1 |
issuance | E L Harris | conversion | trading | ||||||
Principal | |||||||||
OTC Markets Group Inc. | |
OTC Pink Basic Disclosure Guidelines (v3.1 June 24, 2021) | Page 4 of 22 |
01/03/22 | New | 7,500,000 | Common | $0.01 | No | Quick Capital | Reg A | Free | 4(a)1 |
Issuance | LLC | Offering | trading | ||||||
Principal: | |||||||||
Ellon Natan | |||||||||
10/30/21 | New | 3,333,333 | Class A | $0.00001 | No | Everett | Class A | Restricted | |
Issuance | Preferred | Dickson | Preferred | ||||||
10/30/21 | New | 6,666,667 | Class A | $0.00001 | No | Charles | Class A | Restricted | |
Issuance | Preferred | Pereyra | Preferred | ||||||
02/03/22 | New | 12,500,000 | Common | $0.01 | No | Macro | Reg A | Free | 4(a)1 |
Issuance | Services Inc. | Offering | trading |
Richard
Wilson
Principal
Shares Outstanding on Date of This Report:
Ending Balance
Ending Balance: | |
Date 04/30/22 | Common: 217,682,208 |
Preferred: 10,000,000 | |
Use the space below to provide any additional details, including footnotes to the table above:
Subsequent to April 30, 2022 the Company issued 3,000,000 common shares to one corporation.
B. Debt Securities, Including Promissory and Convertible Notes
Use the chart and additional space below to list and describe all outstanding promissory notes, convertible notes, convertible debentures, or any other debt instruments that may be converted into a class of the issuer's equity securities.
Check this box if there are no outstanding promissory, convertible notes or debt arrangements: ☐
Date of | Outstanding | Principal | Interest | Maturity | Conversion Terms (e.g. | Name of Noteholder | Reason for |
Note | Balance ($) | Amount | Accrued | Date | pricing mechanism for | (entities must have | Issuance (e.g. |
Issuance | at | ($) | determining conversion of | individual with voting | Loan, Services, | ||
Issuance | instrument to shares) | / investment control | etc.) | ||||
($) | disclosed). | ||||||
December | $12,000 | $12,000 | $237 | 12/27/19 | May convert to Common | Ken Kerster | Loan |
27, 2018 | shares at a fixed price of | ||||||
$0.005 per share. | |||||||
November | 20,000 | 20,000 | $400 | 11/01/18 | May convert to Common | Corona Software, | Loan |
1, 2017 | shares at a fixed price of | Sanjay Shah, | |||||
$0.005 per share. | Principal | ||||||
OTC Markets Group Inc. | |
OTC Pink Basic Disclosure Guidelines (v3.1 June 24, 2021) | Page 5 of 22 |
This is an excerpt of the original content. To continue reading it, access the original document here.
Attachments
- Original Link
- Original Document
- Permalink
Disclaimer
Springs Rejuvenation Inc. published this content on 09 June 2022 and is solely responsible for the information contained therein. Distributed by Public, unedited and unaltered, on 09 June 2022 13:01:05 UTC.